-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2024-06-26
FAIR:LSE:LSE- (USD)
COMMON STOCK | Asset Management |
Last Closing
USD 0.555Change
-0.01 (-0.89)%Market Cap
USD 23.68BVolume
0.18MN/A
Verdict
Values as of: 2024-06-26
COMMON STOCK | Asset Management |
Last Closing
USD 0.555Change
-0.01 (-0.89)%Market Cap
USD 23.68BVolume
0.18MN/A
Verdict
Currency: USD
Country : UK
Symbol | Name | Price(Change) | Market Cap |
---|---|---|---|
FP:LSE | Fondul Proprietatea S.A. GDR |
N/A |
USD 264.18B |
BHMU:LSE | BH Macro Limited |
N/A |
USD 175.21B |
BPCR:LSE | BioPharma Credit PLC |
N/A |
USD 103.14B |
MNTN:LSE | Schiehallion Fund Ltd |
N/A |
USD 92.77B |
TFG:LSE | Tetragon Financial Group Ltd |
N/A |
USD 83.64B |
RTW:LSE | RTW Venture Fund Ltd |
N/A |
USD 53.54B |
TPOU:LSE | Third Point Investors Limited |
N/A |
USD 53.53B |
SHIP:LSE | Tufton Oceanic Assets Ltd |
N/A |
USD 35.22B |
TMI:LSE | Taylor Maritime Investments Lt.. |
N/A |
USD 32.69B |
III:LSE | 3I Group PLC |
N/A |
USD 30.38B |
N/A
Market Performance vs. Industry/Classification (Asset Management) | Market Performance vs. Exchange | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | 0.91% | 43% | F | 44% | F | ||
Dividend Return | 7.27% | 100% | F | 98% | N/A | ||
Total Return | 8.18% | 72% | C | 68% | D+ | ||
Trailing 12 Months | |||||||
Capital Gain | 14.20% | 73% | C | 66% | D+ | ||
Dividend Return | 16.46% | 97% | N/A | 98% | N/A | ||
Total Return | 30.66% | 90% | A- | 85% | B | ||
Trailing 5 Years | |||||||
Capital Gain | -33.33% | 25% | F | 20% | F | ||
Dividend Return | 31.17% | 91% | A- | 94% | A | ||
Total Return | -2.16% | 46% | F | 37% | F | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | 2.35% | 50% | F | 49% | F | ||
Dividend Return | 12.19% | 71% | C- | 75% | C | ||
Total Return | 9.85% | 87% | B+ | 94% | A | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | 65.42% | 27% | F | 15% | F | ||
Risk Adjusted Return | 18.64% | 68% | D+ | 55% | F | ||
Market Capitalization | 23.68B | 97% | N/A | 85% | B |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
The company had positive total cash flow in the most recent four quarters.
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
This stock has shown top quartile dividend growth in the previous 5 years compared to its sector
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
The stock is trading high compared to its peers median on a price to book value basis.
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.